A flow cytometry-based protocol for syngenic isolation of neurovascular unit cells from mouse and human tissues

Daniel Spitzer, Maryam I. Khel, Tim Pütz, Jenny Zinke, Xiaoxiong Jia, Kathleen Sommer, Katharina Filipski, Frits Thorsen, Thomas M. Freiman, Stefan Günther, Karl H. Plate, Patrick N. Harter, Stefan Liebner, Yvonne Reiss, Mariangela Di Tacchio, Sylvaine Guérit, Kavi Devraj

Published: 2023-02-28 DOI: 10.1038/s41596-023-00805-y

flow cytometry

neurovascular unit

EPAM-ia method

cell isolation

BBB dysfunction

AI 解读

Extended

Extended Data Fig. 1 Assessment of papain concentration in Digestion Mix 1 of the EPAM-ia method on cell yield and viability.

a ) Gating strategy for the isolation of endothelial cells, pericytes (mural cells), astrocytes, and microglia from mouse cerebrum digested according to the EPAM-ia protocol with 0.1% of papain in the Digestion Mix 1, representative experiment of n=3. Initial FSC/SSC dot plot show 1,000,000 events. Percentages refer to the proportion of cells in the previous parental gate. ( b ) Normalized cell events of the four major NVU cell types isolated using different papain concentration in the Digestion Mix 1 (with 0.025%, n=4; 0.05% n=5; 0.1% n=3;). ( c ) Normalized number of dead cells using different concentrations of papain in the Digestion Mix 1.

Extended Data Fig. 2 Assessment of alternative kit-based Digestion Mix 1 and debris removal solution on cell yield, viability, and purity of the isolated NVU cells.

( a ) Schematic indicating with an asterisk the two steps during the cell suspension preparation for which kit based solutions are used. ( b ) Identical gating strategy as in the fully defined EPAM-ia method is applied to obtained microglia, astrocytes, endothelial cells and pericytes (mural cells) from the same brain tissue sample with the kit based Digestion mix 1 and debris removal steps. The FSC/SSC plot shows 1,000,000 events. Percentages refer to the proportion of cells in the previous parental gate. ( c ) Normalized cell events of endothelial cells (EC), pericytes (PC), astrocytes (AC) and microglia (MG) isolated by flow cytometry after tissue dissociation using commercially available solutions for the Digestion Mix 1 and the debris removal (n=5). ( d ) Normalized number of dead cells. ( e - h ) Purity of kit-based and EPAM-ia method sorted cells is assessed by qPCR targeting cell type-specific markers of endothelial cells ( e , Cdh5 , Slca1a1 ), pericytes ( f , Kcnj8 ), astrocytes ( g , Aqp4 , Slc1a3 ), and microglia ( h , Tmem119 ). If no amplification was detected, the ∆Ct value is set at 15 by default (n=4). One way ANOVA followed by Dunnett’s multiple comparison test. *, †, § and $ indicate comparison to EC, PC, AC and MG respectively. *p≤0.05, **p≤0.01, ***p≤0.001, ****p≤0.0001 and ns: not significant. Panels a,e – h adapted with permission from ref. [ 31 ](http://www.nature.com/articles/s41596-023-00805-y#ref-CR31 "Spitzer, D. et al. Profiling the neurovascular unit unveils detrimental effects of osteopontin on the blood–brain barrier in acute ischemic stroke. Acta Neuropathol. http://doi.org/10.1007/s00401-022-02452-1

             \(2022\).") , Springer.

Extended Data Fig. 3 Enrichment analysis of the isolated NVU cell types and the all negative population.

( a ) Detailed transcripts reads for representative cell type markers genes of endothelial cells (EC), pericytes (PC), astrocytes (AC) and microglia (MG) in healthy single brain (n=1) or stroke contralateral hemisphere tissue (n=4, 3-4 mice/preparation). ( b ) Heatmap representing log2 expression of selected choroid plexus and neuronal cell-specific marker genes in endothelial cells, pericytes, astrocytes, microglia and all negative (AN) population isolated from a single mouse cerebrum (n=1). ( c ) FACS plots showing isolation of NeuN positive neurons by EPAM-ia method. Cells isolated by EPAM-ia method were preselected with ACSA2 magnetic beads followed by brief fixation (0.4% PFA) and permeabilization (0.1% Triton X-100) before immunostaining (n=2). Percentages refer to the proportion of cells in the previous parent gate. First SSC/FSC gate shows 200,000 events.

Supplementary information

Supplementary Information

Supplementary Figs. 1–8.

References

The neurovascular unit (NVU), composed of endothelial cells, pericytes, juxtaposed astrocytes and microglia together with neurons, is essential for proper central nervous system functioning. The NVU critically regulates blood–brain barrier (BBB) function,
Introduction
Materials
Procedure
Troubleshooting
Timing
Anticipated results
- References
References
ACKNOWLEDGMENTS

Winkler, E. A. et al. A single-cell atlas of the normal and malformed human brain vasculature. Science 375, eabi7377 (2022).
Liebner, S. et al. Functional morphology of the blood–brain barrier in health and disease. Acta Neuropathol. 135, 311–336 (2018).
Sweeney, M. D., Sagare, A. P. & Zlokovic, B. V. Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat. Rev. Neurol. 14, 133–150 (2018).
Banks, W. A. From blood–brain barrier to blood–brain interface: new opportunities for CNS drug delivery. Nat. Rev. Drug Discov. 15, 275–292 (2016).
Terstappen, G. C., Meyer, A. H., Bell, R. D. & Zhang, W. Strategies for delivering therapeutics across the blood–brain barrier. Nat. Rev. Drug Discov. 20, 362–383 (2021).
Janzer, R. C. & Raff, M. C. Astrocytes induce blood–brain barrier properties in endothelial cells. Nature 325, 253–257 (1987).
Abbott, N. J., Rönnbäck, L. & Hansson, E. Astrocyte–endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 7, 41–53 (2006).
Daneman, R., Zhou, L., Kebede, A. A. & Barres, B. A. Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 468, 562–566 (2010).
Armulik, A. et al. Pericytes regulate the blood–brain barrier. Nature 468, 557–561 (2010).
da Fonseca, A. C. C. et al. The impact of microglial activation on blood–brain barrier in brain diseases. Front. Cell. Neurosci. 8, 362 (2014).
Archie, S. R., Shoyaib, Al,A. & Cucullo, L. Blood–brain barrier dysfunction in CNS disorders and putative therapeutic targets: an overview. Pharmaceutics 13, 1779 (2021).
Phoenix, T. N. et al. Medulloblastoma genotype dictates blood brain barrier phenotype. Cancer Cell 29, 508–522 (2016).
Cucullo, L. et al. Development of a humanized in vitro blood–brain barrier model to screen for brain penetration of antiepileptic drugs. Epilepsia 48, 505–516 (2007).
Lee, Y.-K., Uchida, H., Smith, H., Ito, A. & Sanchez, T. The isolation and molecular characterization of cerebral microvessels. Nat. Protoc. 14, 3059–3081 (2019).
Devraj, G. et al. HIF-1α is involved in blood–brain barrier dysfunction and paracellular migration of bacteria in pneumococcal meningitis. Acta Neuropathol. 140, 183–208 (2020).
Guerit, S. et al. Astrocyte-derived Wnt growth factors are required for endothelial blood-brain barrier maintenance. Prog. Neurobiol. 199, 101937 (2021).
Crouch, E. E. & Doetsch, F. FACS isolation of endothelial cells and pericytes from mouse brain microregions. Nat. Protoc. 13, 738–751 (2018).
Lyck, R. et al. Culture-induced changes in blood–brain barrier transcriptome: implications for amino-acid transporters in vivo. J. Cereb. Blood Flow. Metab. 29, 1491–1502 (2009).
Vanlandewijck, M. et al. A molecular atlas of cell types and zonation in the brain vasculature. Nature 554, 475–480 (2018).
Daneman, R. et al. The mouse blood–brain barrier transcriptome: a new resource for understanding the development and function of brain endothelial cells. PLoS ONE 5, e13741 (2010).
Zhang, Y. et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J. Neurosci. 34, 11929–11947 (2014).
He, L. et al. Analysis of the brain mural cell transcriptome. Sci. Rep. 6, 35108 (2016).
Batiuk, M. Y. et al. An immunoaffinity-based method for isolating ultrapure adult astrocytes based on ATP1B2 targeting by the ACSA-2 antibody. J. Biol. Chem. 292, 8874–8891 (2017).
Kantzer, C. G. et al. Anti-ACSA-2 defines a novel monoclonal antibody for prospective isolation of living neonatal and adult astrocytes. Glia 65, 990–1004 (2017).
Wylot, B., Konarzewska, K., Bugajski, L., Piwocka, K. & Zawadzka, M. Isolation of vascular endothelial cells from intact and injured murine brain cortex-technical issues and pitfalls in FACS analysis of the nervous tissue. Cytom. A 87, 908–920 (2015).
Gurnik, S. et al. Angiopoietin-2-induced blood-brain barrier compromise and increased stroke size are rescued by VE-PTP-dependent restoration of Tie2 signaling. Acta Neuropathol. 131, 753–773 (2016).
Liebner, S. et al. Wnt/β-catenin signaling controls development of the blood–brain barrier. J. Cell Biol. 183, 409–417 (2008).
Bennett, M. L. et al. New tools for studying microglia in the mouse and human CNS. Proc. Natl Acad. Sci. USA 113, E1738–E1746 (2016).
Zhang, Y. et al. Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse. Neuron 89, 37–53 (2016).
Foo, L. C. Purification of rat and mouse astrocytes by immunopanning. Cold Spring Harb. Protoc. 2013, 421–432 (2013).
Spitzer, D. et al. Profiling the neurovascular unit unveils detrimental effects of osteopontin on the blood–brain barrier in acute ischemic stroke. Acta Neuropathol. http://doi.org/10.1007/s00401-022-02452-1 (2022).
Srinivasan, K. et al. Untangling the brain’s neuroinflammatory and neurodegenerative transcriptional responses. Nat. Commun. 7, 11295 (2016).
Sundstrøm, T. et al. Automated tracking of nanoparticle-labeled melanoma cells improves the predictive power of a brain metastasis model. Cancer Res. 73, 2445–2456 (2013).
Daphu, I. et al. In vitro treatment of melanoma brain metastasis by simultaneously targeting the MAPK and PI3K signaling pathways. Int. J. Mol. Sci. 15, 8773–8794 (2014).
Di Tacchio, M. et al. Tumor vessel normalization, immunostimulatory reprogramming, and improved survival in glioblastoma with combined inhibition of PD-1, angiopoietin-2, and VEGF. Cancer Immunol. Res. 7, 1910–1927 (2019).
Richardson, G. M., Lannigan, J. & Macara, I. G. Does FACS perturb gene expression? Cytom. A 87, 166–175 (2015).
Grabert, K. et al. Microglial brain region-dependent diversity and selective regional sensitivities to aging. Nat. Neurosci. 19, 504–516 (2016).
Jurga, A. M., Paleczna, M. & Kuter, K. Z. Overview of general and discriminating markers of differential microglia phenotypes. Front. Cell. Neurosci. 14, 198 (2020).
Haage, V. et al. Comprehensive gene expression meta-analysis identifies signature genes that distinguish microglia from peripheral monocytes/macrophages in health and glioma. Acta Neuropathol. Commun. 7, 20 (2019).
Cahoy, J. D. et al. A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J. Neurosci. 28, 264–278 (2008).
Zhou, L., Sohet, F. & Daneman, R. Purification and culture of central nervous system endothelial cells. Cold Spring Harb. Protoc. 2014, 44–46 (2014).
Navone, S. E. et al. Isolation and expansion of human and mouse brain microvascular endothelial cells. Nat. Protoc. 8, 1680–1693 (2013).
Sheikh, B. N. et al. Systematic identification of cell–cell communication networks in the developing brain. iScience 21, 273–287 (2019).
Liu, L. & Shi, G.-P. CD31: beyond a marker for endothelial cells. Cardiovasc. Res. 94, 3–5 (2012).
Espina, V. et al. Laser-capture microdissection. Nat. Protoc. 1, 586–603 (2006).
Garrido-Gil, P., Fernandez-Rodríguez, P., Rodríguez-Pallares, J. & Labandeira-Garcia, J. L. Laser capture microdissection protocol for gene expression analysis in the brain. Histochem. Cell Biol. 148, 299–311 (2017).
Ståhl, P. L. et al. Visualization and analysis of gene expression in tissue sections by spatial transcriptomics. Science 353, 78–82 (2016).
Vickovic, S. et al. High-definition spatial transcriptomics for in situ tissue profiling. Nat. Methods 16, 987–990 (2019).
Brady, L. et al. Inter- and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profiling. Nat. Commun. 12, 1426 (2021).
Devraj, K. et al. GLUT-1 glucose transporters in the blood–brain barrier: differential phosphorylation. J. Neurosci. Res. 89, 1913–1925 (2011).
Devraj, K. et al. BACE-1 is expressed in the blood–brain barrier endothelium and is upregulated in a murine model of Alzheimer’s disease. J. Cerebr. Blood Flow Metab. 36, 1281–1294 (2016).
Song, H. W. et al. Transcriptomic comparison of human and mouse brain microvessels. Sci. Rep. 10, 12358 (2020).
Leisegang, M. S. et al. Long noncoding RNA MANTIS facilitates endothelial angiogenic function. Circulation 136, 65–79 (2017).
Devraj, K., Guerit, S., Macas, J. & Reiss, Y. An in vivo blood–brain barrier permeability assay in mice using fluorescently labeled tracers. JoVE 132, e57038–e57038 (2018).
Lex, A. & Gehlenborg, N. Sets and intersections. Nat. Methods 11, 779 (2014).
Lex, A., Gehlenborg, N., Strobelt, H., Vuillemot, R. & Pfister, H. UpSet: visualization of intersecting sets. IEEE Trans. Vis. Comput. Gr. 20, 1983–1992 (2014).
Dubinski, D. et al. Controversial roles for dexamethasone in glioblastoma - Opportunities for novel vascular targeting therapies. J. Cereb. Blood Flow. Metab. 39, 1460–1468 (2019).
Bernatz, S. et al. Impact of docetaxel on blood–brain barrier function and formation of breast cancer brain metastases. J. Exp. Clin. Cancer Res. 38, 434 (2019).